Dr. Bleyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
S Hawthorne Rd
Winston Salem, NC 27157Phone+1 336-716-2255
Education & Training
University of Pennsylvania Health SystemFellowship, Nephrology, 1990 - 1992
Johns Hopkins UniversityResidency, Internal Medicine, 1987 - 1990
Baylor College of MedicineClass of 1987
Certifications & Licensure
NC State Medical License 1992 - 2025
PA State Medical License 1991 - 1992
TX State Medical License 1988 - 1992- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
- Fellow (ASNF) American Society of Nephrology
Clinical Trials
- Pilot Study: The Effect of Ergocalciferol on Plasma Mucin-1 Levels Start of enrollment: 2019 Mar 12
Publications & Presentations
PubMed
- 169 citationsTobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population.Anthony J. Bleyer, Lynn Shemanski, Gregory L. Burke, Kimberley J. Hansen, Richard G. Appel
Kidney International. 2000-05-01 - 200 citationsAutosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report.Kai-Uwe Eckardt, Seth L. Alper, Corinne Antignac, Anthony J. Bleyer, Dominique Chauveau
Kidney International. 2015-10-01 - 400 citationsRenal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals.Linda F. Fried, Michael G. Shlipak, Casey Crump, Richard A. Kronmal, Anthony J. Bleyer
Journal of the American College of Cardiology. 2003-04-16
Lectures
- Autosomal Dominant Tubulointerstitial Kidney DiseaseAmerican Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/7/2019
Other
- 3D Computed Tomography Angiography as a Novel Post-Processing Approach in Diagnosis of Pediatric Malignant Bone TumorsAnthony Bleyer, MD, Journal of Pediatric Rehabilitation Medicine
https://www.doximity.com/articles/a54c53b8-d1c9-4467-85f0-1781fe53fe2d
UpToDate, Wolters Kluwer Health - 2012-12-04 - 3D Computed Tomography Angiography as a Novel Post-Processing Approach in Diagnosis of Pediatric Malignant Bone TumorsAnthony Bleyer, MD, Journal of Pediatric Rehabilitation Medicine
https://www.doximity.com/articles/a54c53b8-d1c9-4467-85f0-1781fe53fe2d
UpToDate, Wolters Kluwer Health - 2013-03-21 - 3D Computed Tomography Angiography as a Novel Post-Processing Approach in Diagnosis of Pediatric Malignant Bone TumorsAnthony Bleyer, MD, Journal of Pediatric Rehabilitation Medicine
https://www.doximity.com/articles/a54c53b8-d1c9-4467-85f0-1781fe53fe2d
UpToDate, Wolters Kluwer Health - 2012-02-16 - Join now to see all
Press Mentions
Natera to Present New Renasight Data at ASN Kidney Week 2024October 22nd, 2024- Wake Forest University School of Medicine Kidney Disease Efforts Highlighted in FDA Award to Critical Path InstituteSeptember 30th, 2024
- Hemodialysis Timing May Affect Post-Surgery Death RiskNovember 30th, 2022
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
